Deroy & Devereaux Private Investment Counsel’s Regeneron Pharmaceuticals REGN Stock Holding History

Deroy & Devereaux Private Investment Counsel’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$256K	Hold	410	–	–	0.01%	161
2026 Q1	$317K	Hold	410	–	–	0.02%	146
2025 Q4	$316K	Hold	410	–	–	0.02%	145
2025 Q3	$231K	Hold	410	–	–	0.01%	161
2025 Q2	$215K	Hold	410	–	–	0.01%	161
2025 Q1	$260K	Hold	410	–	–	0.02%	150
2024 Q4	$292K	Hold	410	–	–	0.02%	151
2024 Q3	$431K	Hold	410	–	–	0.02%	136
2024 Q2	$431K	Hold	410	–	–	0.03%	133
2024 Q1	$395K	Hold	410	–	–	0.02%	143
2023 Q4	$360K	Hold	410	–	–	0.02%	145
2023 Q3	$337K	Hold	410	–	–	0.02%	149
2023 Q2	$295K	Hold	410	–	–	0.02%	157
2023 Q1	$337K	Hold	410	–	–	0.03%	120
2022 Q4	$296K	Hold	410	–	–	0.02%	125
2022 Q3	$282K	Hold	410	–	–	0.02%	119
2022 Q2	$242K	Hold	410	–	–	0.02%	129
2022 Q1	$286K	Sell	410 -5	-1%	-$3.16K	0.02%	138
2021 Q4	$262K	Buy	415 +5	+1%	+$3.07K	0.02%	137
2021 Q3	$248K	Hold	410	–	–	0.02%	138
2021 Q2	$229K	Buy	+410	New	+$208K	0.02%	144
2020 Q4	–	Sell	-410	Closed	-$230K	–	145
2020 Q3	$230K	Hold	410	–	–	0.02%	134
2020 Q2	$256K	Hold	410	–	–	0.03%	126
2020 Q1	$200K	Buy	+410	New	+$169K	0.03%	129

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Deroy & Devereaux Private Investment Counsel's REGN Position: Q2 2026 in Review

Deroy & Devereaux Private Investment Counsel held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 410 shares worth $256K. The position accounts for 0.01% of the portfolio, ranked #161.

Deroy & Devereaux Private Investment Counsel first reported a position in REGN in Q1 2020 and has held it in 24 quarters since. The position peaked at $431K in Q3 2024. 789 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Deroy & Devereaux Private Investment Counsel held 410 shares of Regeneron Pharmaceuticals worth $256K as of Q2 2026.
Deroy & Devereaux Private Investment Counsel left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
Regeneron Pharmaceuticals made up 0.01% of Deroy & Devereaux Private Investment Counsel's portfolio in Q2 2026, its #161 holding.
Deroy & Devereaux Private Investment Counsel first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 24 quarters since.
Deroy & Devereaux Private Investment Counsel's Regeneron Pharmaceuticals position peaked at $431K in Q3 2024.
789 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Deroy & Devereaux Private Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.